Nature's Sunshine Products, Inc.
General ticker "NATR" information:
- Sector: Consumer Staples
- Industry: Packaged Foods
- Capitalization: $352.4M (TTM average)
Nature's Sunshine Products, Inc. does not follow the US Stock Market performance with the rate: -0.8%.
Estimated limits based on current volatility of 1.0%: low 13.85$, high 14.20$
Factors to consider:
- Total employees count: 806 (-1.6%) as of 2025
- US accounted for 28.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Geopolitical risks, Supply chain disruptions, Manufacturing risks, Cybersecurity threats
- Current price 13.2% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [16.16$, 24.53$]
- 2026-12-31 to 2027-12-31 estimated range: [17.52$, 26.48$]
Financial Metrics affecting the NATR estimates:
- Positive: with PPE of 17.3 at the end of fiscal year the price was neutral
- Positive: 8.77 < Operating cash flow per share per price, % of 8.98
- Positive: Inventory ratio change, % of 0.42 <= 1.34
- Positive: 4.60 < Operating profit margin, % of 5.15
- Positive: 58.56 < Shareholder equity ratio, % of 61.86 <= 69.38
- Negative: Industry operating profit margin (median), % of -0.43 <= 0.59
- Negative: Industry operating cash flow per share per price (median), % of 3.35 <= 3.66
- Positive: Interest expense per share per price, % of 0.02 <= 0.07
Short-term NATR quotes
Long-term NATR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $445.32MM | $454.36MM | $480.14MM |
| Operating Expenses | $426.57MM | $434.27MM | $455.40MM |
| Operating Income | $18.75MM | $20.09MM | $24.74MM |
| Non-Operating Income | $1.45MM | $-1.67MM | $5.07MM |
| Interest Expense | $0.07MM | $0.15MM | $0.10MM |
| R&D Expense | $0.00MM | $1.70MM | $0.00MM |
| Income(Loss) | $20.20MM | $18.43MM | $29.81MM |
| Taxes | $3.79MM | $10.53MM | $9.36MM |
| Net Income(Loss)* | $15.08MM | $7.70MM | $19.52MM |
| Stockholders Equity | $159.54MM | $160.99MM | $161.55MM |
| Inventory | $66.89MM | $59.44MM | $68.31MM |
| Assets | $249.77MM | $240.85MM | $261.15MM |
| Operating Cash Flow | $41.23MM | $25.30MM | $35.32MM |
| Capital expenditure | $10.48MM | $10.97MM | $6.48MM |
| Investing Cash Flow | $-10.48MM | $-10.97MM | $-6.48MM |
| Financing Cash Flow | $-7.96MM | $-9.90MM | $-23.77MM |
| Earnings Per Share** | $0.79 | $0.41 | $1.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.